-
-
1.5 Measure Type
-
1.14 Numerator
Inpatient hospitalizations for patients who develop acute kidney injury (AKI) (stage 2 or greater) during the encounter, as evidenced by: • A subsequent increase in serum creatinine value at least 2 times higher than the lowest serum creatinine value, and the increased value is greaterthan the highest sex-specific normal value for serum creatinine; or • Kidney dialysis (continuous renal replacement therapy (CRRT), hemodialysis or peritoneal dialysis) initiated 48 hours or more after the start of theencounter.
-
1.15 Denominator
Inpatient hospitalizations for patients 18 years of age or older at the start if the encounter without a diagnosis of obstetrics, with a length of stay of 48 hours or longer who had at least one serum creatinine value after 48 hours from the start of the encounter.
-
OLD 1.12 MAT output not attachedAttached1.13a Data dictionary not attachedNo
-
Most Recent Endorsement ActivityEndorsed Patient Safety Fall 2022Initial EndorsementLast Updated
-
StewardCenters for Medicare & Medicaid ServicesSteward Organization POC EmailMeasure Developer Secondary Point Of Contact
United States
-
-
-
Risk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Fall 2022 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Fall 2022 “Intent to Submit.” Battelle took over the E&M work for the Fall 2022 cycle after developers and/or stewards submitted their full measure information to NQF, which for CBE #3713e, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2024-02/3713e.zip
Battelle took over the E&M work beginning with the public comment period to close the E&M committees for the post-comment meeting, convening the CSAC to render a final endorsement decision, and executing the appeals period.